Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

231.18
-15.5600-6.31%
Post-market: 231.540.3600+0.16%19:40 EDT
Volume:2.02M
Turnover:475.78M
Market Cap:30.85B
PE:41.14
High:251.71
Open:248.21
Low:230.06
Close:246.74
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:2.02
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:22.78
PE(LYR):99.22

Loading ...

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-01

Reuters
·
5 hours ago

Movement Alert|Alnylam Pharmaceuticals Falls 5.13% in Regular Trading, Multiple Banks Cut Price Targets Pressuring Sentiment

Market Focus
·
Yesterday

Compass Pathways Names Kelley Boucher Chief People Officer

Reuters
·
Sep 30

US Research Roundup-Alnylam Pharmaceuticals, Carvana, MongoDB

Reuters
·
Sep 30

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Revvity (RVTY)

TIPRANKS
·
Sep 26

Alnylam Pharmaceuticals Price Target Maintained with a $455.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 21

Analysts Offer Insights on Healthcare Companies: Innate Pharma (IPHA) and Alnylam Pharma (ALNY)

TIPRANKS
·
Sep 21

Analysts’ Top Healthcare Picks: Alnylam Pharma (ALNY), Scholar Rock Holding (SRRK)

TIPRANKS
·
Sep 16

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-15

Reuters
·
Sep 15

Alnylam Pharmaceuticals Price Target Raised to $260.00/Share from $230.00 by Jefferies

Dow Jones
·
Sep 08

Movement Alert|Alnylam Pharmaceuticals Falls 5.3% in Pre-Market Trading, Trading at $251.34

Market Focus
·
Sep 08

Alnylam price target raised to $260 from $230 at Jefferies

TIPRANKS
·
Sep 08

Alnylam's Zilebesiran Sees Commercial Opportunity From Baxfendy Launch, Oppenheimer Says

MT Newswires Live
·
Sep 04

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-09-02

Reuters
·
Sep 03

Alnylam Pharmaceuticals Inc Stock (ALNY) Moved Up by 7.90% on Sep 2: Facts Behind the Movement

TradingKey
·
Sep 03

Movement Alert|Alnylam Pharmaceuticals Rises 5.22% in Regular Trading, Competitor Data Setback and Analyst Optimism on Next-Gen Pipeline

Market Focus
·
Sep 02

Alnylam to Webcast Investor Conference Presentations in September

Reuters
·
Sep 02

Alnylam Pharmaceuticals Price Target Maintained with a $455.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 02

Alnylam's Latest Data Strengthen Outlook for Nucresiran, TRITON-CM, Oppenheimer Says

MT Newswires Live
·
Aug 31

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-08-31

Reuters
·
Aug 31